Publicado
Measuring Individual Benefits of Medical Treatments Using Longitudinal Hospital Data with Non-Ignorable Missing Responses Caused by Patient Discharge: Application to the Study of Benefits of Pain Management Post Spinal Fusion
Medición de los beneficios individuales de tratamientos médicos a partir de datos hospitalarios longitudinales con respuestas faltantes no ignorables causadas por la alta del paciente: Aplicación al estudio de los beneficios del tratamiento contra el dolor después de una fusión espinal
DOI:
https://doi.org/10.15446/rce.v45n2.101597Palabras clave:
Electronic health records, Empirical Bayesian prediction, Joint mixed models, Non-ignorable missing data, Observational data, Random effects (en)Datos faltantes no ignorables, Datos observacionales, Efectos aleatorios, Modelos mixtos conjuntos, Predicción Bayesiana empírica, Registros de salud electrónicos (es)
Descargas
Electronic health records (EHR) provide valuable resources for longitudinal studies and understanding risk factors associated with poor clinical outcomes. However, they may not contain complete follow-ups, and the missing data may not be at random since hospital discharge may depend in part on expected but unrecorded clinical outcomes that occur after patient discharge. These non-ignorable missing data requires appropriate analysis methods. Here, we are interested in measuring and analyzing individual treatment benefits of medical treatments in patients recorded in EHR databases. We present a method for predicting individual benefits that handles non-ignorable missingness due to hospital discharge. The longitudinal clinical outcome of interest is modeled simultaneously with the hospital length of stay using a joint mixed-effects model, and individual benefits are predicted through a frequentist approach: the empirical Bayesian approach. We illustrate our approach by assessing individual pain management benefits to patients who underwent spinal fusion surgery. By calculating sample percentiles of empirical Bayes predictors of individual benefits, we examine the evolution of individual benefits over time. We additionally compare these percentiles with percentiles calculated with a Monte Carlo approach. We showed that empirical Bayes predictors of individual benefits do not only allow examining benefits in specific patients but also reflect overall population trends reliably.
Los registros de salud electrónicos (RSE) suministran recursos valiosos para estudios longitudinales y para comprender los factores de riesgo asociados con pobres resultados clínicos. Sin embargo, estos podrían no contener seguimientos completos, y los datos faltantes podrían no ser al azar, debido a que el alta hospitalaria puede depender en parte de resultados clínicos esperados pero no registrados que ocurren después de dar de alta al paciente. Esta ausencia de datos no ignorables requiere métodos apropiados de análisis. Aquí estamos interesados en medir y analizar beneficios individuales de tratamientos médicos en pacientes consignados en bases de datos RSE. Proponemos un método para predecir beneficios individuales el cual maneja los datos faltantes debidos al alta hospitalaria. La respuesta clínica longitudinal de interés se modela junto con el tiempo de estadía en el hospital usando un modelo conjunto de efectos mixtos, y los beneficios individuales se predicen por medio de un enfoque frecuentista: el enfoque Bayesiano empírico. Nuestro enfoque es ilustrado evaluando los beneficios individuales del tratamiendo para el dolor en pacientes que fueron sometidos a cirugía de fusión espinal. Aquí examinamos la evolución de los beneficios individuales a través del tiempo mediante el cálculo de los percentiles muestrales de los predictores de Bayes empíricos de los beneficios individuales. También comparamos estos percentiles con percentiles calculados mediante un enfoque Monte Carlo. Los resultados mostraron que los predictores de Bayes empíricos de beneficios individuales no sólo permiten examinar beneficios en pacientes específicos sino que también reflejan confiablemente las tendencias poblacionales globales.
Referencias
Adogwa, O., Parker, S. L., Shau, D. N., Mendenhall, S. K., Bydon, A., Cheng, J. S., Asher, A. L. & McGirt, M. J. (2013), 'Preoperative Zung depression scale predicts patient satisfaction independent of the extent of improvement after revision lumbar surgery', The Spine Journal 13, 501-506. DOI: https://doi.org/10.1016/j.spinee.2013.01.017
Albers, D. J., Elhadad, N., Claassen, J., Perotte, R., Goldstein, A. & Hripcsak, G. (2018), 'Estimating summary statistics for electronic health record laboratory data for use in high-throughput phenotyping algorithms', Journal of Biomedical Informatics 78, 87-101. DOI: https://doi.org/10.1016/j.jbi.2018.01.004
Anderson, J. T., Haas, A. R., Percy, R., Woods, S. T., Ahn, U. M. & Ahn, N. U. (2015), 'Clinical depression is a strong predictor of poor lumbar fusion outcomes among workers' compensation subjects', Spine 40, 748-756. DOI: https://doi.org/10.1097/BRS.0000000000000863
Andrews, N. & Cho, H. (2018), 'Validating effectiveness of subgroup identification for longitudinal data', Statistics in Medicine 37, 98-106. DOI: https://doi.org/10.1002/sim.7500
Armero, C., Forte, A., Perpiñán, H., Sanahuja, M. J. & Agustí, S. (2018), 'Bayesian joint modeling for assessing the progression of chronic kidney disease in children', Statistical Methods in Medical Research 27, 298-311. DOI: https://doi.org/10.1177/0962280216628560
Arnold, L. M., Palmer, R. H., Gendreau, R. M. & Chen, W. (2012), 'Relationships among pain, depressed mood, and global status in -bromyalgia patients: post hoc analyses of a randomized, placebo-controlled trial of milnacipran', Psychosomatics 53, 371-379. DOI: https://doi.org/10.1016/j.psym.2012.02.005
Botts, S., Diaz, F. J., Santoro, V., Spina, E., Muscatello, M. R., Cogollo, M., Castro, F. E. & de Leon, J. (2008), 'Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model', Progress in Neuro-Psychopharmacology & Biological Psychiatry 32, 1453-1458. DOI: https://doi.org/10.1016/j.pnpbp.2008.04.018
Cho, H., Wang, P. & Qu, A. (2017), 'Personalized treatment for longitudinal data using unspecified random-effects model', Statistica Sinica 27, 187-205. DOI: https://doi.org/10.5705/ss.202015.0120
Crowther, M. J., Abrams, K. R. & Lambert, P. C. (2012), 'Flexible parametric joint modelling of longitudinal and survival', Statistics in Medicine 31, 4456-4471. DOI: https://doi.org/10.1002/sim.5644
De Gruttola, V. & Tu, X. M. (1994), 'Modelling progression of CD4-lymphocyte count and its relationship to survival time', Biometrics 50, 1003-1014. DOI: https://doi.org/10.2307/2533439
de Leon, J. (2012), 'Evidence-based medicine versus personalized medicine: are they enemies?', Journal of Clinical Psychopharmacology 32, 153-164. DOI: https://doi.org/10.1097/JCP.0b013e3182491383
Diaz, F. J. (2016), 'Measuring the individual benefit of a medical or behavioral treatment using generalized linear mixed-effects models', Statistics in Medicine 35, 4077-4092. DOI: https://doi.org/10.1002/sim.7005
Diaz, F. J. (2018), 'Construction of the design matrix for generalized linear mixed-effects models in the context of clinical trials of treatment sequences', Revista Colombiana de Estadística 41, 191-233. DOI: https://doi.org/10.15446/rce.v41n2.63332
Diaz, F. J. (2019), 'Estimating individual benefits of medical or behavioral treatments in severely ill patients', Statistical Methods in Medical Research 28, 911-927. DOI: https://doi.org/10.1177/0962280217739033
Diaz, F. J. (2021), 'Using population crossover trials to improve the decision process regarding treatment individualization in N-of-1 trials', Statistics in Medicine 40, 4345-4361. DOI: https://doi.org/10.1002/sim.9030
Diaz, F. J., Berg, M. J., Krebill, R., Welty, T., Gidal, B. E., Alloway, R. & Privitera, M. (2013), 'Random-effects linear modeling and sample size tables for two special crossover designs of average bioequivalence studies: the four-period, two-sequence, two-formulation and six-period, three-sequence, three-formulation designs', Clinical Pharmacokinetics 52, 1033-1043. DOI: https://doi.org/10.1007/s40262-013-0103-4
Diaz, F. J., Cogollo, M. R., Spina, E., Santoro, V., Rendon, D. M. & de Leon, J. (2012b), 'Drug Dosage Individualization Based on a Random-Effects Linear Model', Journal of Biopharmaceutical Statistics 22, 463-484. DOI: https://doi.org/10.1080/10543406.2010.547264
Diaz, F. J. & de Leon, J. (2013), 'The mathematics of drug dose individualization should be built with random effects linear models', Therapeutic Drug Monitoring 35, 276-277. DOI: https://doi.org/10.1097/FTD.0b013e318283e3c6
Diaz, F. J., Eap, C. B., Ansermot, N., Crettol, S., Spina, E. & de Leon, J. (2014), 'Can valproic acid be an inducer of clozapine metabolism?', Pharmacopsychiatry 47, 89-96. DOI: https://doi.org/10.1055/s-0034-1371866
Diaz, F. J., Rivera, T. E., Josiassen, R. C. & de Leon, J. (2007), 'Individualizing drug dosage by using a random intercept linear model', Statistics in Medicine 26, 2052-2073. DOI: https://doi.org/10.1002/sim.2636
Diaz, F. J., Santoro, V., Spina, E., Cogollo, M., Rivera, T. E., Botts, S. & de Leon, J. (2008), 'Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables', Pharmacopsychiatry 41, 81-91. DOI: https://doi.org/10.1055/s-2007-1004591
Diaz, F. J., Yeh, H.-W. & de Leon, J. (2012a), 'Role of Statistical Random-Effects Linear Models in Personalized Medicine', Current Pharmacogenomics and Personalized Medicine 10, 22-32. DOI: https://doi.org/10.2174/1875692111201010022
Edelstein, C. L. (2008), 'Biomarkers of acute kidney injury', Advances in Chronic Kidney Disease 15, 222-234. DOI: https://doi.org/10.1053/j.ackd.2008.04.003
Frees, E. W. (2004), Longitudinal and Panel Data, Cambridge University Press, Cambridge. DOI: https://doi.org/10.1017/CBO9780511790928
Gaudin, D., Krafcik, B. M., Mansour, T. R. & Alnemari, A. (2017), 'Considerations in spinal fusion surgery for chronic lumbar pain: psychosocial factors, rating scales, and perioperative patient education-a review of the literature', World Neurosurgery 98, 21-27. DOI: https://doi.org/10.1016/j.wneu.2016.10.124
Gerbershagen, H. J., Pogatzki-Zahn, E., Aduckathil, S., Peelen, L. M., Kappen, T. H., van Wijck, A. J., Kalkman, C. J. & Meissner, W. (2014), 'Procedur-especific risk factor analysis for the development of severe postoperative pain', Anesthesiology 120, 1237-1245. DOI: https://doi.org/10.1097/ALN.0000000000000108
Gewandter, J. S., McDermott, M. P., He, H., Gao, S., Cai, X., Farrar, J. T., Katz, N. P., Markman, J. D., Senn, S., Turk, D. C. & Dworkin, R. H. (2019), 'Demonstrating heterogeneity of treatment effects among patients: an overlooked but important step toward precision medicine', Clinical Pharmacology & Therapeutics 106, 204-210. DOI: https://doi.org/10.1002/cpt.1372
Greden, J. F. (2009), 'Treating depression and pain', Journal of Clinical Psychiatry 70(6), e16. DOI: https://doi.org/10.4088/JCP.8005cc3c
Gronski, L., Martinson, W., Singh, K. P. & Ryan, J. (2012), 'Utility of daily troponin orders for identifying acute myocardial infarction patients for quality improvement', Critical Pathway in Cardiology 11, 74-76. DOI: https://doi.org/10.1097/HPC.0b013e31824c0459
Hedeker, D. & Gibbons, R. D. (2006), Longitudinal Data Analysis, Wiley-Interscience, Hoboken, NJ.
Hickey, G. L., Philipson, P., Jorgensen, A. & Kolamunnage-Dona, R. (2018), 'joineRML: a joint model and software package for time-to-event and multivariate longitudinal outcomes', BMC Medical Research Methodology 18, 50. [doi.org/10.1186/s12874-018-0502-1]. DOI: https://doi.org/10.1186/s12874-018-0502-1
Ibrahim, J. G. & Molenberghs, G. (2009), 'Missing data methods in longitudinal studies: a review', Test (Madr) 18, 1-43. DOI: https://doi.org/10.1007/s11749-009-0138-x
Johnson, N. L. (1949), 'Systems of Frequency Curves Generated by Methods of Translation', Biometrika 36, 149-176. DOI: https://doi.org/10.1093/biomet/36.1-2.149
Laird, N. M. (1998), 'Missing data in longitudinal studies', Statistics in Medicine 7, 305-315. DOI: https://doi.org/10.1002/sim.4780070131
Lesa-re, E., Rizopoulos, D. & Tsonaka, R. (2007), 'The logistic transform for bounded outcome scores', Biostatistics 8, 72-85. DOI: https://doi.org/10.1093/biostatistics/kxj034
Little, R. J. A. & Rubin, D. B. (2002), Statistical Analysis with Missing Data, Second Edition, Wiley, New York. DOI: https://doi.org/10.1002/9781119013563
Lotzke, H., Jakobsson, M., Brisby, H., Gutke, A., Hägg, O., Smeets, R., den Hollander, M., Olsson, L. E. & Lundberg, M. (2016), 'Use of the PREPARE (PREhabilitation, Physical Activity and exeRcisE) program to
improve outcomes after lumbar fusion surgery for severe low back pain: a study protocol of a person-centred randomised controlled trial', BMC Musculoskeletal Disorders 17(1), 349. [doi: 10.1186/s12891-016-1203-8]. DOI: https://doi.org/10.1186/s12891-016-1203-8
Miksad, R. A. & Abernethy, A. P. (2018), 'Harnessing the power of real-world evidence (RWE): A checklist to ensure regulatory-grade Data Quality', Clinical Pharmacology & Therapeutics 103, 202-205. DOI: https://doi.org/10.1002/cpt.946
Pantazis, N. & Touloumi, G. (2010), 'Analyzing longitudinal data in the presence of informative drop-out: The jmre1 command', Stata Journal 10, 226-251. DOI: https://doi.org/10.1177/1536867X1001000204
Papageorgiou, G., Mau-, K., Tomer, A. & Rizopoulos, D. (2019), 'An overview of joint modeling of time-to-event and longitudinal outcomes', Annual Review of Statistics and its Application 6, 223-240. DOI: https://doi.org/10.1146/annurev-statistics-030718-105048
Ruberg, S. J., Chen, L. & Wang, Y. (2010), 'The mean does not mean as much anymore: finding sub-groups for tailored therapeutics', Clinical Trials 7, 574-583. DOI: https://doi.org/10.1177/1740774510369350
Schluchter, M. D. (1992), 'Methods for the analysis of informatively censored longitudinal data', Statistics in Medicine 11, 1861-1870. DOI: https://doi.org/10.1002/sim.4780111408
Schluchter, M. D. & Piccorelli, A. V. (2019), 'Shared parameter models for joint analysis of longitudinal and survival data with left truncation due to delayed entry - Applications to cystic fibrosis', Statistical Methods in Medical Research 28, 1489-1507. DOI: https://doi.org/10.1177/0962280218764193
Senn, S. (2016), 'Mastering variation: variance components and personalized medicine', Statistics in Medicine 35, 966-977. DOI: https://doi.org/10.1002/sim.6739
Shardell, M. & Ferrucci, L. (2018), 'Joint mixed-effects models for causal inference with longitudinal data', Statistics in Medicine 37, 829-846. DOI: https://doi.org/10.1002/sim.7567
Shaw, A. D., Mythen, M. G., Shook, D., Hayashida, D. K., Zhang, X., Skaar, J. R., Iyengar, S. S. & Munson, S. H. (2018), 'Pulmonary artery catheter use in adult patients undergoing cardiac surgery: a retrospective, cohort study', Perioperative Medicine (Lond) 7, 24. [doi.org/10.1186/s13741-018-0103-x]. DOI: https://doi.org/10.1186/s13741-018-0103-x
Shirafkan, H., Mahmoudi-Gharaei, J., Fotouhi, A., Moza-arpur, S. A., Yaseri, M. & Hoseini, M. (2020), 'Individualizing the dosage of Methylphenidate in children with attention deficit hyperactivity disorder', BMC Medical Research Methodology 20, 56. [doi.org/10.1186/s12874-020-00934-y]. DOI: https://doi.org/10.1186/s12874-020-00934-y
Touloumi, G., Pocock, S. J., Babiker, A. G. & Darbyshire, J. H. (1999), 'Estimation and comparison of rates of change in longitudinal studies with informative drop-outs', Statistics in Medicine 18, 1215-1233. DOI: https://doi.org/10.1002/(SICI)1097-0258(19990530)18:10<1215::AID-SIM118>3.0.CO;2-6
Trivedi, M. H. (2004), 'The link between depression and physical symptoms', Primary Care Companion of the Journal of Clinical Psychiatry 6(Suppl 1), 12-16.
Urman, R. D., Boing, E. A., Pham, A. T., Khangulov, V., Fain, R., Nathanson, B. H., Zhang, X., Wan, G. J., Lovelace, B. & Cirillo, J. (2018), 'Improved outcomes associated with the use of intravenous acetaminophen for management of acute post-surgical pain in cesarean sections and hysterectomies', Journal of Clinical Medicine Research 10, 499-507. DOI: https://doi.org/10.14740/jocmr3380w
Wang, Z. & Diaz, F. J. (2020), 'A graphical approach to assess the goodness-of-fit of random-effects linear models when the goal is to measure individual benefits of medical treatments in severely ill patients', BMC Medical Research Methodology 20, 193. [doi.org/10.1186/s12874-020-01054-3]. DOI: https://doi.org/10.1186/s12874-020-01054-3
Weinmann, C., Komann, M. & Meissner, W. (2017), 'Tough cookies: the older the patients, the more pain tolerating?', European Journal of Anesthesiology 34(Suppl 55), 215.
Woodward, M. (2014), Epidemiology: Study Design and Data Analysis, Third Edition, Chapman & Hall/CRC, Boca Raton, FL. DOI: https://doi.org/10.1201/b16343
Zhang, X., de Leon, J., Crespo-Facorro, B. & Diaz, F. J. (2020), 'Measuring individual beneffets of psychiatric treatment using longitudinal binary outcomes: Application to antipsychotic benefits in non-cannabis and cannabis users', Journal of Biopharmaceutical Statistics 30, 916-940. DOI: https://doi.org/10.1080/10543406.2020.1765371
Zhu, X. & Qu, A. (2016), 'Individualizing drug dosage with longitudinal data', Statistics in Medicine 35, 4474-4488. DOI: https://doi.org/10.1002/sim.7016
Cómo citar
APA
ACM
ACS
ABNT
Chicago
Harvard
IEEE
MLA
Turabian
Vancouver
Descargar cita
CrossRef Cited-by
1. Francisco J Diaz. (2024). Measuring the individualization potential of treatment individualization rules: Application to rules built with a new parametric interaction model for parallel-group clinical trials. Statistical Methods in Medical Research, 33(8), p.1355. https://doi.org/10.1177/09622802241259172.
Dimensions
PlumX
Visitas a la página del resumen del artículo
Descargas
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons (CC Atribución 4.0) que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).